The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5
Science Advances · 20.06.2025 · 11 (25)
DOI: 10.1126/sciadv.adv2417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 20.06.2025. Verfasst von Man Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Glutamine, Carcinoma, Renal Cell, Amino Acid Transport System ASC. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Glutamine reprogramming plays a crucial role in the growth and survival of clear cell renal cell carcinoma (ccRCC), although the mechanisms governing its regulation are still not fully understood. We demonstrate that the RNA demethylase fat mass and obesity-associated gene (FTO) drives glutamine reprogramming to support ccRCC growth and survival. Genetic and pharmacologic inhibition of FTO in ccRCC cells impaired glutamine-derived reductive carboxylation, depleted pyrimidines, and increased reactive oxygen species. This led to increased DNA damage and reduced survival, which could be rescued by pyrimidine nucleobases or the antioxidant N -acetylcysteine. Mechanistically, FTO demethylates the glutamine transporter solute carrier family 1 member 5 (SLC1A5) messenger RNA to promote its expression. Restoration of SLC1A5 expression in FTO-knockdown cells rescued metabolic and survival defects. FTO inhibition reduced ccRCC tumor xenograft and PDX growth under the renal capsule. Our findings indicate that FTO is an epitranscriptomic regulator of ccRCC glutamine reprogramming and highlight the therapeutic potential of targeting FTO for the treatment of ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA.
- Department of Urology, Stanford University, Stanford, CA 94305, USA.
- Department of Oncology, University of Oxford, Oxford, UK.
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94158, USA.
- Department of Obstetrics and Gynecology, Stanford University, Stanford, CA 94305, USA.
ORCID-Profile: Man Zhao, Dalin Zhang, Haowen Jiang, Suchitra Natarajan, Kaushik N Thakkar, Quynh Thu Le, Amato J Giaccia, James D Brooks, Jiangbin Ye, Erinn B Rankin
Förderung
- NCI NIH HHS
Zitieren
APA
Zhao, M., Zhang, D., Jiang, H., Kuganesan, N., Natarajan, S., Pu, L., Thakkar, K. N., Zhao, H., Le, Q. T., Giaccia, A. J., Brooks, J. D., Peehl, D. M., Ye, J., & Rankin, E. B. (2025). The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5. Science Advances, 11(25). https://doi.org/10.1126/sciadv.adv2417
Vancouver
Zhao M, Zhang D, Jiang H, Kuganesan N, Natarajan S, Pu L, et al. The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5. Science Advances. 2025;11(25). doi:10.1126/sciadv.adv2417
BibTeX
@article{Zhao2025,
author = {Zhao, Man and Zhang, Dalin and Jiang, Haowen and Kuganesan, Nishanth and Natarajan, Suchitra and Pu, Leighton and Thakkar, Kaushik N and Zhao, Hongjuan and Le, Quynh Thu and Giaccia, Amato J and Brooks, James D and Peehl, Donna M and Ye, Jiangbin and Rankin, Erinn B},
title = {The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {25},
doi = {10.1126/sciadv.adv2417}
}
EUVIMED